Market Cap 1.24B
Revenue (ttm) 1.61B
Net Income (ttm) -6.94M
EPS (ttm) N/A
PE Ratio 6.90
Forward PE 6.98
Profit Margin -0.43%
Debt to Equity Ratio 1.73
Volume 805,400
Avg Vol 1,111,212
Day's Range N/A - N/A
Shares Out 77.91M
Stochastic %K 93%
Beta 1.21
Analysts Hold
Price Target $17.67

Company Profile

Integra LifeSciences Holdings Corporation manufactures and sells surgical instrument, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cran...

Industry: Medical Devices
Sector: Healthcare
Phone: 609 275 0500
Fax: 609 750 4277
Address:
1100 Campus Road, Princeton, United States
Estimize
Estimize Oct. 21 at 12:00 PM
Wall St is expecting 0.43 EPS for $IART Q3 [Reporting 10/30 BMO] http://www.estimize.com/intro/iart?chart=historical&metric_name=eps&utm_co
0 · Reply
Winning_calls
Winning_calls Oct. 20 at 2:37 AM
$IART pick me up @ $15.12
0 · Reply
JarvisFlow
JarvisFlow Oct. 15 at 3:14 PM
Truist Securities has updated their rating for Integra Lifesciences ( $IART ) to Hold with a price target of 15.
0 · Reply
Estimize
Estimize Oct. 8 at 12:06 PM
Wall St is expecting 0.43 EPS for $IART Q3 [Reporting 10/29 BMO] http://www.estimize.com/intro/iart?chart=historical&metric_name=eps&utm_co
0 · Reply
Kaltycoon
Kaltycoon Sep. 24 at 5:06 PM
$CLPT $IART can we get some love at IART
0 · Reply
Estimize
Estimize Sep. 24 at 12:06 PM
Wall St is expecting 0.43 EPS for $IART Q3 [Reporting 10/29 BMO] http://www.estimize.com/intro/iart?chart=historical&metric_name=eps&utm_co
0 · Reply
JessePhelps536
JessePhelps536 Sep. 22 at 8:13 AM
$IART Healthcare equipment consistency. Steady uptrend intact. Institutional demand steady. Low volatility.
0 · Reply
ZacksResearch
ZacksResearch Sep. 16 at 3:55 PM
Is $IART struggling or seizing opportunities? 🤔 🌍 Strong international growth and CSS segment prospects 📉 Macroeconomic challenges and liquidity concerns 📊 Stock down 12.1% in the past year with a Zacks Rank #3 Full analysis here 👉 https://www.zacks.com/stock/news/2752209/should-you-continue-to-hold-integra-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2752209-body-12646&ADID=SYND_STOCKTWITS_TWEET_2_2752209_BODY_12646
0 · Reply
ZacksResearch
ZacksResearch Sep. 16 at 2:55 PM
$IART — hold or fold? 🤔 The big question now is whether keeping Integra in your portfolio still makes sense, as the article weighs the case for investors. Full breakdown here 👉 https://www.zacks.com/stock/news/2752209/should-you-continue-to-hold-integra-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2752209-teaser-12616&ADID=SYND_STOCKTWITS_TWEET_2_2752209_TEASER_12616
0 · Reply
FillPhantom
FillPhantom Sep. 15 at 10:08 AM
$IART Resilient cash flows expected; monitor pricing power and competition
0 · Reply
Latest News on IART
Jan De Witte joins GHO Capital as Operating Partner

Feb 11, 2025, 4:30 AM EST - 9 months ago

Jan De Witte joins GHO Capital as Operating Partner

RMD


Estimize
Estimize Oct. 21 at 12:00 PM
Wall St is expecting 0.43 EPS for $IART Q3 [Reporting 10/30 BMO] http://www.estimize.com/intro/iart?chart=historical&metric_name=eps&utm_co
0 · Reply
Winning_calls
Winning_calls Oct. 20 at 2:37 AM
$IART pick me up @ $15.12
0 · Reply
JarvisFlow
JarvisFlow Oct. 15 at 3:14 PM
Truist Securities has updated their rating for Integra Lifesciences ( $IART ) to Hold with a price target of 15.
0 · Reply
Estimize
Estimize Oct. 8 at 12:06 PM
Wall St is expecting 0.43 EPS for $IART Q3 [Reporting 10/29 BMO] http://www.estimize.com/intro/iart?chart=historical&metric_name=eps&utm_co
0 · Reply
Kaltycoon
Kaltycoon Sep. 24 at 5:06 PM
$CLPT $IART can we get some love at IART
0 · Reply
Estimize
Estimize Sep. 24 at 12:06 PM
Wall St is expecting 0.43 EPS for $IART Q3 [Reporting 10/29 BMO] http://www.estimize.com/intro/iart?chart=historical&metric_name=eps&utm_co
0 · Reply
JessePhelps536
JessePhelps536 Sep. 22 at 8:13 AM
$IART Healthcare equipment consistency. Steady uptrend intact. Institutional demand steady. Low volatility.
0 · Reply
ZacksResearch
ZacksResearch Sep. 16 at 3:55 PM
Is $IART struggling or seizing opportunities? 🤔 🌍 Strong international growth and CSS segment prospects 📉 Macroeconomic challenges and liquidity concerns 📊 Stock down 12.1% in the past year with a Zacks Rank #3 Full analysis here 👉 https://www.zacks.com/stock/news/2752209/should-you-continue-to-hold-integra-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2752209-body-12646&ADID=SYND_STOCKTWITS_TWEET_2_2752209_BODY_12646
0 · Reply
ZacksResearch
ZacksResearch Sep. 16 at 2:55 PM
$IART — hold or fold? 🤔 The big question now is whether keeping Integra in your portfolio still makes sense, as the article weighs the case for investors. Full breakdown here 👉 https://www.zacks.com/stock/news/2752209/should-you-continue-to-hold-integra-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2752209-teaser-12616&ADID=SYND_STOCKTWITS_TWEET_2_2752209_TEASER_12616
0 · Reply
FillPhantom
FillPhantom Sep. 15 at 10:08 AM
$IART Resilient cash flows expected; monitor pricing power and competition
0 · Reply
HodlCommander
HodlCommander Sep. 12 at 5:46 PM
Integrating quantum sensors could shape the future of neurosurgery. $IART (Integra LifeSciences) gets a mention in AlphaBriefing’s article on quantum sensors and BCIs: https://www.alphabriefing.com/quantum-sensors-inside-living-cells-the-next-frontier-for-brain-computer-interfaces/
0 · Reply
Estimize
Estimize Sep. 10 at 12:06 PM
Wall St is expecting 0.43 EPS for $IART Q3 [Reporting 10/29 BMO] http://www.estimize.com/intro/iart?chart=historical&metric_name=eps&utm_co
0 · Reply
Estimize
Estimize Aug. 27 at 12:09 PM
Wall St is expecting 0.44 EPS for $IART Q3 [Reporting 10/29 BMO] http://www.estimize.com/intro/iart?chart=historical&metric_name=eps&utm_co
0 · Reply
WinStreakMaster
WinStreakMaster Aug. 27 at 9:27 AM
$IART price action looks indecisive, could go either way with volume shift.
0 · Reply
Quantum_Capital_LLC
Quantum_Capital_LLC Aug. 22 at 4:30 PM
$IART I don't think anyone saw this post. +10% today and still have room to run. Do your DD. Long term
1 · Reply
Quantum_Capital_LLC
Quantum_Capital_LLC Aug. 20 at 7:41 PM
$IART why does it feel like IART will have a massive run in the next few days? Do your DD. Long term
0 · Reply
twincam
twincam Aug. 17 at 5:57 PM
$MDXG $IART Medicare’s new prior auth rules (Jan 1, 2026) could shake wound care stocks. 👀 $MDXG + $IART (placental graft leaders) face higher hurdles for reimbursement. ⚠️ Risk: delayed approvals & tighter coverage. 🚀 Watch volatility on any CMS updates. https://finance.yahoo.com/news/trump-administration-tiptoes-into-testing-prior-authorization-in-traditional-medicare-143012089.html
0 · Reply
traderhr
traderhr Aug. 16 at 12:51 PM
The chart indicates a notable recovery since May, with prices forming a series of higher lows and nearing a potential reversal point. Recently, the price has approached a crucial resistance $IART #tradeideas #swingtrading $SPX https://www.traderhr.com/charts-to-watch-iart-2/
0 · Reply
traderhr
traderhr Aug. 13 at 12:48 PM
The chart for Integra LifeSciences shows a notable consolidation phase, with price action fluctuating within a defined range around the $12.50 level. A recent upward movement has brought the $IART #tradeideas #swingtrading $SPX
0 · Reply
Estimize
Estimize Aug. 13 at 12:09 PM
Wall St is expecting 0.44 EPS for $IART Q3 [Reporting 10/29 BMO] http://www.estimize.com/intro/iart?chart=historical&metric_name=eps&utm_co
0 · Reply
Wonderfulnewz
Wonderfulnewz Aug. 2 at 2:41 PM
$IART quick and dirty margin of safety (mos)analysis : they bought Codman for 2.7 x sales back in 2017. Let’s apply 1/2 that multiple to that segment and 1x for the rest . Total rev 2025: 1,680 Codman is 70%: $1176 x1.35 =$1,587.60 Tissue is 30%: $504 x1.00=$504 Cash on hand: $250 Company MOS value: 2,350m —————- Ev: $1500 net debt plus 77m shares at $12= $2,400 Forecast $2.20 eps 2025 = 5.5 times earnings  Therefore- I’d say $12 and under is a great bargain. If the can avoid additional ship holds we’ll be much higher as IV is probably in the mid $20S with mid single growth and fda concerns dissipating 🤞
0 · Reply
Joby099
Joby099 Jul. 31 at 11:42 AM
0 · Reply